[ Price : $8.95]
AstraZeneca says new study data on Tagrisso (osimertinib) show an improved overall survival trend in certain patients with non-sma...[ Price : $8.95]
FDA warns Denver, CO-based Exer Labs about illegally marketing its Exer Scan device that has Quality System Regulation violations.[ Price : $8.95]
FDA says it received 803 medical device reports on Bayers withdrawn Essure birth control implant in 2024, the lowest number since ...[ Price : $8.95]
A Buchanan Ingersoll & Rooney petition asks FDA to continue the product-specific guidance restrictions on ANDAs citing Waylis canc...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion cautions Taiho Oncology about misleading efficacy presentations in a Web page for i...[ Price : $8.95]
FDA sends Nyxoah an approvable letter on its PMA for the Genio system, a neuromodulation device for treating obstructive sleep apn...[ Price : $8.95]
Johnson & Johnson says Rybrevant outperformed AstraZenecas Tagrisso in a head-to-head study in the first-line treatment of patient...[ Price : $8.95]
Covidien recalls its Shiley Adult Flexible Tracheostomy Tube with TaperGuard Cuff Reusable Inner Cannula due to safety concerns if...